Story perspectives

Psychedelics' Promise: Ketamine and Psilocybin Transform Mental Health

3/14/2026

Summary

Story summary

In 2000, Yale University researchers found ketamine significantly improved depression symptoms after a single dose.
Finding sparked interest in psychedelics for mental health treatment.
Johns Hopkins University researchers studied psilocybin and reported profound psychological effects on volunteers.
A 2010 Yale University study showed ketamine promotes dendritic growth in the prefrontal cortex, supporting mood regulation.
Blocking proteins necessary for dendritic growth negated the ketamine-related behavioral benefits in rats with induced depression.

1 of 1

Story summary

In 2000, Yale University researchers found ketamine significantly improved depression symptoms after a single dose.
Finding sparked interest in psychedelics for mental health treatment.
Johns Hopkins University researchers studied psilocybin and reported profound psychological effects on volunteers.
A 2010 Yale University study showed ketamine promotes dendritic growth in the prefrontal cortex, supporting mood regulation.
Blocking proteins necessary for dendritic growth negated the ketamine-related behavioral benefits in rats with induced depression.